Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of glucose-dependent insulinotropic polypeptide receptor (GIPR) signalling in brain pericytes in the context of neuroinflammation
EF 2023-24
Résumé
Neurodegenerative diseases, such as Alzheimer's disease, have been closely linked to prolonged inflammation in the brain, leading to irreversible neurological damage. Recent efforts have been made to identify effective treatments that protect the brain against inflammation. Metabolic hormones released from the gut—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) may play an essential role in regulating inflammation through a gut-brain axis. Drugs mimicking the action of GLP-1 appear to be effective in protecting brain cells against inflammation. However, the roles of the related gut hormone GIP in regulating brain inflammation remain to be explored. Recent research has revealed GIP receptors are found in a type of brain cells called pericytes, which may be promising modulators of brain inflammation. To explore this possibility, we will uncover the role of brain pericyte-GIP receptor signalling in modulating brain inflammation. Brain inflammation will be studied in both normal mice and mice with the absence of GIP receptors specifically in the brain pericytes. Through the targeted pharmacological administration of various GIP analogues to these mice with brain inflammation, our goal is to evaluate alterations in gene and protein biomarkers of inflammation, thereby elucidating the role of GIP and how it acts through brain pericyte GIP receptors. The significance of this research lies in its potential to contribute valuable insights that could be translated into pharmacological advancements for the treatment of neurodegenerative diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
505980
Name
Cui Fiona X
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of glucose-dependent insulinotropic polypeptide receptor (GIPR) signalling in brain pericytes in the context of neuroinflammation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood-Brain Barrier; Brain Pericyte; Central Nervous System (Cns); Glucagon-Like Peptide-1 (Glp-1); Glucose-Dependent Insulinotropic Polypeptide (Gip); Incretins; Metabolism; Neurodegenerative Diseases; Neuroinflammation; Receptor Analogues
Abstract
Neurodegenerative diseases, such as Alzheimer's disease, have been closely linked to prolonged inflammation in the brain, leading to irreversible neurological damage. Recent efforts have been made to identify effective treatments that protect the brain against inflammation. Metabolic hormones released from the gut—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) may play an essential role in regulating inflammation through a gut-brain axis. Drugs mimicking the action of GLP-1 appear to be effective in protecting brain cells against inflammation. However, the roles of the related gut hormone GIP in regulating brain inflammation remain to be explored. Recent research has revealed GIP receptors are found in a type of brain cells called pericytes, which may be promising modulators of brain inflammation. To explore this possibility, we will uncover the role of brain pericyte-GIP receptor signalling in modulating brain inflammation. Brain inflammation will be studied in both normal mice and mice with the absence of GIP receptors specifically in the brain pericytes. Through the targeted pharmacological administration of various GIP analogues to these mice with brain inflammation, our goal is to evaluate alterations in gene and protein biomarkers of inflammation, thereby elucidating the role of GIP and how it acts through brain pericyte GIP receptors. The significance of this research lies in its potential to contribute valuable insights that could be translated into pharmacological advancements for the treatment of neurodegenerative diseases.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cui, Fiona X
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~